HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.

AbstractBACKGROUND:
Insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), human epidermal growth factor receptor-type 2 (HER2), and c-Met are members of the receptor tyrosine kinases (RTKs). The associations between the RTK status [protein expression and gene copy number (GCN)] and patient characteristics and between the RTK status and prognosis remain undetermined.
MATERIALS AND METHODS:
The study included 140 patients who underwent surgery for thymic tumors. Protein expression was evaluated by immunohistochemistry (IHC) and GCN was evaluated by bright-field in situ hybridization (BISH). The correlations between the RTK status and clinicopathological findings were examined.
RESULTS:
IGF-1R protein was frequently detected in thymic carcinoma (83.8%) and EGFR in thymic tumors (91.4%). Thirty-six and 39 tumors were BISH high for IGF-1R and EGFR, respectively: 28 and 25 exhibited high polysomy; 8 and 14 exhibited gene amplification. No tumor was positive for HER2 or c-Met by IHC and BISH. Multivariate analysis revealed that IGF-1R gene amplification (P = 0.027), thymic carcinoma histology, and higher tumor stage were significantly correlated with an adverse prognosis.
CONCLUSIONS:
Thymic epithelial tumors frequently express IGF-1R and/or EGFR proteins. IGF-1R gene amplification is suggested to define an unfavorable subset for thymic epithelial tumors.
AuthorsT Mimae, K Tsuta, T Kondo, H Nitta, T M Grogan, M Okada, H Asamura, H Tsuda
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 23 Issue 12 Pg. 3129-3137 (Dec 2012) ISSN: 1569-8041 [Electronic] England
PMID22700994 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • EGFR protein, human
  • ERBB2 protein, human
  • ErbB Receptors
  • Proto-Oncogene Proteins c-met
  • Receptor, ErbB-2
  • Receptor, IGF Type 1
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (genetics)
  • ErbB Receptors (genetics)
  • Female
  • Gene Dosage
  • Gene Expression
  • Gene Expression Regulation, Neoplastic (genetics)
  • Humans
  • In Situ Hybridization
  • Male
  • Middle Aged
  • Neoplasms, Glandular and Epithelial (genetics, surgery)
  • Proto-Oncogene Proteins c-met (genetics)
  • Receptor, ErbB-2 (genetics)
  • Receptor, IGF Type 1 (genetics)
  • Thymoma (genetics, surgery)
  • Thymus Neoplasms (genetics, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: